Advanced search
Publication Cover
Pharmaceutical Development and Technology Volume 26, 2021 - Issue 9
Submit an article Journal homepage
190
Views
9
CrossRef citations to date
0
Altmetric
Research Articles

Acriflavine-loaded solid lipid nanoparticles: preparation, physicochemical characterization, and anti-proliferative properties

Somayeh Vandghanoonia Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, IranView further author information
,
Forough Rasoulianb Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, IranView further author information
,
Masoud Eskandanic Department of Animal Science, Faculty of Agricultural Sciences, University of Mohaghegh Ardabili, Ardabil, IranView further author information
,
Sattar Akbari Nakhjavanid Department of Molecular Medicine, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, IranView further author information
&
Morteza Eskandanie Research Center for Pharmaceutical Nanotechnology, Tabriz University of Medical Sciences, Tabriz, IranCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-2282-4871View further author information
ORCID Icon
Pages 934-942 | Received 17 Dec 2020, Accepted 29 Jul 2021, Published online: 25 Aug 2021

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Long Wu, Yun Meng, Yuhang Xu & Xiaoqin Chu. (2022) Improved uptake and bioavailability of cinnamaldehyde via solid lipid nanoparticles for oral delivery. Pharmaceutical Development and Technology 27:10, pages 1038-1048.
Read now
Jafar Akbari, Majid Saeedi, Fatemeh Ahmadi, Seyyed Mohammad Hassan Hashemi, Amirhossein Babaei, Sadra Yaddollahi, Seyyed Sohrab Rostamkalaei, Kofi Asare-Addo & Ali Nokhodchi. (2022) Solid lipid nanoparticles and nanostructured lipid carriers: a review of the methods of manufacture and routes of administration. Pharmaceutical Development and Technology 27:5, pages 525-544.
Read now

Articles from other publishers (7)

Leila Mehrannia, Balal Khalilzadeh, Reza Rahbarghazi, Morteza Milani, Gulsah Saydan Kanberoglu, Hadi Yousefi & Nevin Erk. (2023) Electrochemical Biosensors as a Novel Platform in the Identification of Listeriosis Infection. Biosensors 13:2, pages 216.
Crossref
Sevda JafariAtabak BakhshaeiMorteza Eskandani & Ommoleila Molavi. (2022) Silibinin-Loaded Nanostructured Lipid Carriers for Growth Inhibition of Cisplatin-Resistant Ovarian Cancer Cells. ASSAY and Drug Development Technologies 20:8, pages 339-348.
Crossref
Masoud Eskandani, Bahman Navidshad, Morteza Eskandani, Somayeh Vandghanooni, Farzad Mirzaei Aghjehgheshlagh, Ali Nobakht & Amir Ali Shahbazfar. (2022) The effects of L-carnitine-loaded solid lipid nanoparticles on performance, antioxidant parameters, and expression of genes associated with cholesterol metabolism in laying hens. Poultry Science 101:12, pages 102162.
Crossref
Ramin Eskandani, Mohammad Kazempour, Raheleh Farahzadi, Zohreh Sanaat, Morteza Eskandani, Khosro Adibkia, Somayeh Vandghanooni & Ahad Mokhtarzadeh. (2022) Engineered nanoparticles as emerging gene/drug delivery systems targeting the nuclear factor-κB protein and related signaling pathways in cancer. Biomedicine & Pharmacotherapy 156, pages 113932.
Crossref
Sankha Bhattacharya, Satyam Sharma & Bhupendra G. Prajapati. (2022) Development of D-α-Tocopherol polyethylene glycol 1000 succinate fabricated nanostructural lipid carrier of sorafenib tosylate for metastatic colorectal targeting application: Stability, physical characterization, cytotoxicity, and apoptotic studies against SW48 cells PTEN. Frontiers in Oncology 12.
Crossref
Kinga Piorecka, Jan Kurjata & Wlodzimierz A. Stanczyk. (2022) Acriflavine, an Acridine Derivative for Biomedical Application: Current State of the Art. Journal of Medicinal Chemistry 65:17, pages 11415-11432.
Crossref
Abdelrahman Y. Sherif, Gamaleldin I. Harisa, Fars K. Alanazi, Fahd A. Nasr & Ali S. Alqahtani. (2022) Engineered Nanoscale Lipid-Based Formulation as Potential Enhancer of Gefitinib Lymphatic Delivery: Cytotoxicity and Apoptotic Studies Against the A549 Cell Line. AAPS PharmSciTech 23:6.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.